Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged inAllNewsSportCultureLifestyleMillions of women in the UK with polyendocrine metabolic ovarian syndrome (PMOS) are to be offered annual health reviews by health officials. The National Institute for Health and Care Excellence (Nice) announced these yearly check-ups to monitor symptoms, assess treatment and manage long-term health risks. PMOS, formerly known as polycystic ovarian syndrome (PCOS), was renamed to address diagnostic delays and reduce the focus solely on ovarian cysts. Nice's new draft guideline recommends earlier diagnosis for women with irregular periods and signs of excessive male hormones, as the condition affects three to four million women in the UK and is often underdiagnosed. However, the guideline does not recommend laser or light therapies for excess hair growth (hirsutism) due to a lack of clinical evidence and cost-effectiveness concerns, suggesting contraceptive pills as an alternative. In fullThe ‘common but overlooked’ condition that millions of UK women will now be reviewed forThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in
Millions of women to receive yearly reviews for ‘often overlooked’ condition
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged inAllNewsSportCultureLifestyleMillions of women in the UK with polyendocrine metabolic ovarian syndrome (PMOS) are to be offered annual health reviews by health officials. The National Institute for Health and Care Excellence (Nice) announced these yearly check-ups to monitor symptoms, assess treatment and manage long-term health risks. PMOS, formerly known as polycystic ovarian syndrome (PCOS), was renamed to address diagnostic delays and reduce the focus solely on ovarian cysts. Nice's new draft guideline recommends earlier diagnosis for women with irregular periods and signs of excessive male hormones, as the condition affects three to four million women in the UK and is often underdiagnosed. However, the guideline does not recommend laser or light therapies for excess hair growth (hirsutism) due to a lack of clinical evidence and cost-effectiveness concerns, suggesting contraceptive pills as an alternative. In fullThe ‘common but overlooked’ condition that millions of UK women will now be reviewed forThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in
